Trading Update and Notice of Results

RNS Number : 9532O
Inspiration Healthcare Group PLC
25 August 2017
 

25 August 2017

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

 

Inspiration Healthcare Group plc ("Inspiration", the "Company" or the "Group")

Trading Update and Notice of Results

 

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, is pleased to announce a trading update for the six months ended 31 July 2017 and the date of the half year results.

 

Trading Update

 

The Company had a satisfactory first half and the Board envisages the results for the six months to 31 July 2017 will be in line with expectations. Expectations for the full year remain unchanged.

 

Notice of Results

 

The Company will publish results for the six months ended 31 July 2017 on Tuesday 26 September 2017.

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

01709 761000

 

Nominated Adviser & Broker Cenkos Securities plc Bobbie Hilliam (NOMAD) 

0207 397 8900

 

Cadogan PR                                                                                         

Alex Walters

07771 713608

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLDTIISFID
UK 100

Latest directors dealings